166 related articles for article (PubMed ID: 34425650)
1. 4H12, a Murine Monoclonal Antibody Directed against Myosin Heavy Chain-9 Expressed on Acinar Cell Carcinoma of Pancreas with Potential Therapeutic Application.
Balouchi-Anaraki S; Ahmadvand S; Safaei A; Ghaderi A
Iran Biomed J; 2021 Sep; 25(5):310-22. PubMed ID: 34425650
[TBL] [Abstract][Full Text] [Related]
2. Production of a Mouse Monoclonal Antibody Against Mortalin by Whole Cell Immunization.
Rezaei M; Ghaderi A
Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):169-175. PubMed ID: 28719245
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal Antibody Production Against Vimentin by Whole Cell Immunization in a Mouse Model.
Rezaei M; Ghaderi A
Iran J Biotechnol; 2018 May; 16(2):e1802. PubMed ID: 30805388
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a new human acinar cell carcinoma cell line, Faraz-ICR, from pancreas.
Rezaei M; Hosseini A; Nikeghbalian S; Ghaderi A
Pancreatology; 2017; 17(2):303-309. PubMed ID: 28215484
[TBL] [Abstract][Full Text] [Related]
5. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
Hall JC; Marlow LA; Mathias AC; Dawson LK; Durham WF; Meshaw KA; Mullin RJ; Synnott AJ; Small DL; Krishna M; von Hoff D; Schüler J; Hart SN; Couch FJ; Colon-Otero G; Copland JA
J Transl Med; 2016 May; 14(1):129. PubMed ID: 27165126
[TBL] [Abstract][Full Text] [Related]
6. Characterization of new monoclonal antibodies directed against normal human exocrine pancreas and pancreatic adenocarcinomas.
Sinn HP; Brown SA; Thompson JS
Pancreas; 1993 May; 8(3):279-88. PubMed ID: 8483869
[TBL] [Abstract][Full Text] [Related]
7. Production of three monoclonal antibodies specifically reactive respectively with the ductal, acinar and islet cells of the human pancreas.
Shibata K; Kobayashi T; Matsuura N; Shimano T; Mori T
Jpn J Clin Oncol; 1991 Feb; 21(1):13-21. PubMed ID: 1648632
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of monoclonal antibody against a triple negative breast cancer cell line.
Ghaderi F; Ahmadvand S; Ramezani A; Montazer M; Ghaderi A
Biochem Biophys Res Commun; 2018 Oct; 505(1):181-186. PubMed ID: 30243716
[TBL] [Abstract][Full Text] [Related]
9. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.
La Rosa S; Franzi F; Marchet S; Finzi G; Clerici M; Vigetti D; Chiaravalli AM; Sessa F; Capella C
Virchows Arch; 2009 Feb; 454(2):133-42. PubMed ID: 19066953
[TBL] [Abstract][Full Text] [Related]
10. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.
Yang LJ; Wang WL
World J Gastroenterol; 2002 Oct; 8(5):808-14. PubMed ID: 12378620
[TBL] [Abstract][Full Text] [Related]
11. Alteration of a membrane associated marker in transplantable rat pancreatic acinar cell carcinoma.
Parsa I; Reddy JK
Carcinogenesis; 1984 Jun; 5(6):709-13. PubMed ID: 6373043
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies as probes for plasma membrane domains in the exocrine pancreas.
De Lisle RC; Logsdon CD; Hootman SR; Williams JA
J Histochem Cytochem; 1988 Aug; 36(8):1043-51. PubMed ID: 3292643
[TBL] [Abstract][Full Text] [Related]
13. The generation of monoclonal antibodies against human pancreatic exocrine cancer: a study of six different immunisation regimes.
Grant AG; Harris PM; Heyderman E; Larkin SE; Pym B; Hermon-Taylor J
Br J Cancer; 1985 Oct; 52(4):543-50. PubMed ID: 4063133
[TBL] [Abstract][Full Text] [Related]
14. [Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].
Hong B; Qian Y; Yao HP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):511-6. PubMed ID: 24167131
[TBL] [Abstract][Full Text] [Related]
15. The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma.
Yasumoto M; Hamabashiri M; Akiba J; Ogasawara S; Naito Y; Taira T; Nakayama M; Daicho A; Yamasaki F; Shimamatsu K; Ishida Y; Kaji R; Okabe Y; Nakashima O; Ohshima K; Nakashima M; Sata M; Yano H
J Clin Pathol; 2012 Apr; 65(4):327-32. PubMed ID: 22228907
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival in a patient with acinar cell carcinoma of pancreas. A case report and review of literature.
Antoine M; Khitrik-Palchuk M; Saif MW
JOP; 2007 Nov; 8(6):783-9. PubMed ID: 17993731
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen.
Yoo C; Kim BJ; Kim KP; Lee JL; Kim TW; Ryoo BY; Chang HM
Cancer Res Treat; 2017 Jul; 49(3):759-765. PubMed ID: 27857025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
